Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

B of A Securities Upgrades PulteGroup to Buy

B of A Securities analyst Rafe Jadrosich upgrades PulteGroup (NYSE:PHM) from Underperform to Buy.

byBenzinga Newsdesk

February 28, 2022

1 minute read

B of A Securities analyst Rafe Jadrosich upgrades PulteGroup (NYSE:PHM) from Underperform to Buy.

JMP Securities Maintains Market Outperform on Altimmune, Lowers Price Target to $26

By Benzinga Newsdesk

Today, 11:59 AM

JMP Securities analyst Jonathan Wolleben maintains Altimmune (NASDAQ:ALT) with a Market Outperform and lowers the price target from $28 to $26.

ALT

JMP Securities Initiates Coverage On Vor Biopharma with Market Outperform Rating, Announces Price Target of $40

By Benzinga Newsdesk

Today, 11:59 AM

JMP Securities analyst Silvan Tuerkcan initiates coverage on Vor Biopharma (NASDAQ:VOR) with a Market Outperform rating and announces Price Target of $40.

VOR

News

Elon Musk Tweets ‘Oh man, this year has been such a supply chain nightmare & it’s not over! I will provide an updated product roadmap on next earnings call.’

By Benzinga Newsdesk

Today, 11:59 AM

https://www.twitter.com/i/status/1465423422238994436

TSLA

Piper Sandler Downgrades Comstock Res to Underweight, Lowers Price Target to $16

By Benzinga Newsdesk

Today, 11:59 AM

Piper Sandler analyst Kashy Harrison downgrades Comstock Res (NYSE:CRK) from Neutral to Underweight and lowers the price target from $19 to $16.

CRK

B of A Securities Upgrades PulteGroup to Buy

Related Posts

JMP Securities Maintains Market Outperform on Altimmune, Lowers Price Target to $26

JMP Securities Initiates Coverage On Vor Biopharma with Market Outperform Rating, Announces Price Target of $40

Elon Musk Tweets ‘Oh man, this year has been such a supply chain nightmare & it’s not over! I will provide an updated product roadmap on next earnings call.’

Piper Sandler Downgrades Comstock Res to Underweight, Lowers Price Target to $16